Prognostic Value of the 18F‐FDG PET/CT and Haematological Parameters in Head and Neck Cancer

Abstract

ABSTRACTIntroductionFluorine 18‐fluoro‐glucose positron emission tomography/computed tomography (18F‐FDG PET/CT) is commonly used for the staging of head and neck cancer. This study aimed to evaluate the correlation between 18F‐FDG PET/CT, haematological parameters and prognosis in patients with advanced head and neck cancer.MethodsThis was a single‐institutional retrospective study of 83 patients with advanced head and neck squamous cell carcinoma (HNSCC) who underwent 18F‐FDG PET/CT imaging before initial treatment between 2014 and 2018. 18F‐FDG PET/CT after treatment was performed in 57 patients. The prognostic parameters of the pre‐ and post‐treatment maximum standardised uptake value (SUVmax), metabolic tumour volume (MTV), total lesion glycolysis (TLG) of primary tumours and haematological parameters were analysed to evaluate the association between overall survival (OS) and progression‐free survival (PFS).ResultsPre‐MTV, pre‐TLG and post‐SUVmax were significantly associated with poor OS and PFS (p < 0.05). Haematological parameters, including pretreatment neutrophil/lymphocyte ratio and C‐reactive protein/albumin ratio, were associated with 18F‐FDG PET/CT parameters. In multivariate analysis, post‐SUVmax was an independent prognostic factor for OS and PFS.ConclusionA correlation between PET/CT metabolic and haematological parameters was observed. The volume and intensity of 18F‐FDG uptake region, in addition to haematological parameters, are feasible markers for predicting the progression of HNSCC in daily practice. Further, post‐SUVmax could be an independent parameter for predicting poor survival.